Sanofi CEO Christopher A. Viehbacher poses for photographers as he arrives for its annual results in Paris, Thursday, Feb. 6, 2014. The French drug maker said Thursday its earnings soared in the fourth quarter as lower restructuring costs offset a hefty charge related to one of its key multiple sclerosis treatments. (AP Photo/Michel Euler)
Featured Photo Galleries
